Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C -> A:T mutations of the TP53 tumor suppressor gene
Authors:
Open Access
- 1 October 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 22 (10) , 1715-1719
Abstract
O6-Methylguanine-DNA methyltransferase (MGMT) is a repair protein that specifically removes promutagenic alkyl groups from the O6 position of guanine in DNA. Repair of O6-alkylguanine adducts by tumour cells has been implicated in drug resistance since it reduces the cytotoxicity of alkylating chemotherapeutic agents. We assessed promoter methylation of the MGMT gene in astrocytic brain tumours by methylation-specific PCR. MGMT promoter methylation was detected in 26 of 54 (48%) low-grade diffuse astrocytomas (WHO grade II) and in 12 of 16 (75%) of secondary glioblastomas (WHO grade IV) that had progressed from low-grade astrocytomas. The frequency of MGMT methylation was significantly lower in primary (de novo) glioblastomas (13 of 36, 36%, P = 0.0155). The majority of low-grade astrocytomas with MGMT methylation (24/26, 92%) contained a TP53 mutation, whereas only 11 out of 28 (39%) cases without MGMT methylation carried a TP53 mutation (P < 0.0001). Furthermore, G:C → A:T transition mutations at CpG sites were significantly more frequent in low-grade astrocytomas with MGMT methylation (15/26, 58%) than in those without (3/28, 11%, P = 0.0004). These results suggest that loss of MGMT expression as a result of promoter methylation, which frequently occurs at an early stage in the pathway leading to secondary glioblastomas, appears to be associated with increased frequency of TP53 mutations, in particular G:C → A:T transitions.Keywords
This publication has 26 references indexed in Scilit:
- Promoter Hypermethylation of the RB1 Gene in GlioblastomasLaboratory Investigation, 2001
- Repair of O6-alkylguanine by alkyltransferasesMutation Research - Reviews in Mutation Research, 2000
- Loss of Heterozygosity on Chromosome 10 Is More Extensive in Primary (De Novo) Than in Secondary GlioblastomasLaboratory Investigation, 2000
- Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factorOncogene, 1999
- Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomasActa Neuropathologica, 1997
- Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- Kinetic and DNA-Binding Properties of Recombinant Human O6-Methylguanine-DNA MethyltransferaseArchives of Biochemistry and Biophysics, 1993
- Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras geneCancer, 1992
- Clonal expansion of p53 mutant cells is associated with brain tumour progressionNature, 1992
- Inhibition of the hepatic o6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agentsBiochemical Pharmacology, 1989